DME Capital Management’s DMK Pharmaceuticals DMK Stock Holding History
Bought
Maintained
Sold
Other funds holding DMK
DME Capital Management's DMK Position: Q4 2021 in Review
DME Capital Management sold out of DMK Pharmaceuticals (DMK) in Q4 2021, closing a stake of 4,177 shares — an estimated $283K sold.
DME Capital Management first reported a position in DMK in Q2 2021 and held it in 2 quarters. The position peaked at $1.1M in Q2 2021. 49 funds tracked by Wall St. Rank hold DMK as of Q4 2021.
- DME Capital Management reported no remaining DMK Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
- DME Capital Management sold 4,177 DMK Pharmaceuticals shares in Q4 2021, an estimated $283K.
- DME Capital Management first reported a position in DMK Pharmaceuticals in Q2 2021 and held it in 2 quarters.
- DME Capital Management's DMK Pharmaceuticals position peaked at $1.1M in Q2 2021.
- 49 funds tracked by Wall St. Rank held DMK Pharmaceuticals as of Q4 2021.
Based on DME Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.